hydroxyindoleacetic acid has been researched along with methylimidazoleacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlman, H; Dahlström, A; Enerbäck, L; Granérus, G; Nilsson, O; Persson, S; Tisell, LE | 1 |
| Asgharian, B; Bashir, S; Bordi, C; Crafa, P; Entsuah, LK; Ferraro, G; Gibril, F; Jensen, RT; Ojeaburu, JV | 1 |
2 other study(ies) available for hydroxyindoleacetic acid and methylimidazoleacetic acid
| Article | Year |
|---|---|
Two cases of gastric carcinoids: diagnostic and therapeutic aspects.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Hydroxyindoleacetic Acid; Imidazoles; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Pentagastrin; Stomach Neoplasms | 1988 |
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoid Tumor; Chromogranin A; Chromogranins; Female; Gastrinoma; Histamine; Humans; Hydroxyindoleacetic Acid; Imidazoles; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neoplasm Proteins; Pancreatic Neoplasms; Prospective Studies; Sensitivity and Specificity; Serotonin; Stomach Neoplasms; Zollinger-Ellison Syndrome | 2002 |